PDF is committed to using your funds efficiently to support our mission. To see how funds are spent, browse our financial information.
Around and about the Community
Third Annual Copa Benefit is Most Successful Yet!
On an unseasonably warm November night, more than 600 people (our largest crowd to date!) swarmed to the Parkinson's Disease Foundation's Third Annual Carnaval at the Copa to raise funds for PDF's research programs. New York City's legendary Copacabana nightclub served for the third time on November 15 as the venue for an evening of fun and philanthropy, especially among young professionals in the metropolitan area. Total proceeds of the event, including profits from spectacular live and silent auctions, were nearly $220,000 - the best yet!
Peter Dorn, PDF Board Member, event Co-Chair and co-owner of the Copa, welcomed the crowd and explained the potential that Parkinson's science holds if it is properly funded. Taking Peter's words to heart, guests bid on the fantastic silent auction items and packed around casino tables to give all that they could to support Parkinson's research. Throughout the night, the band GDO Soul provided their rocking sound to keep the dance floor full.
The talented and impressive volunteer steering committee, headed by event Co-Chairs Peter Dorn, Sharon Klein and Doug Stern, joins PDF in thanking the many people who helped make this event a success. This group would particularly like to thank our gracious Honorary Chair Julianna Margulies; dynamic emcee Bruce Beck; the outstanding Copa staff; and of course the friends and sponsors whose contributions made the entire event so wonderful. Special thanks are also extended to the anonymous friend of PDF who generously donated a matching gift of $50,000.
Stay tuned for information on the next Carnaval at the Copa!
PDF & AANF Initiate Joint Fellowship
The Parkinson's Disease Foundation (PDF) and the American Academy of Neurology Foundation (AANF) are pleased to announce a two-year Clinician Scientist Development Award of $75,000 per year.
The PDF-AANF Clinician Scientist Development Award will foster the productivity of young research clinician scientists who have demonstrated the potential to make significant contributions to Parkinson's disease clinical research.
"We're thrilled to work with AANF on this exciting new venture that further reinforces our commitment to recruiting top talent to choose a career in Parkinson's clinical research and care," said Dr. Stanley Fahn, PDF's Scientific Director. "This grant is in line with several of PDF's other programs that are designed to ensure that Parkinson's research is being conducted by the best and brightest in the field."
The grant will support two years of research training at an institution where talented clinicians focus on Parkinson's science. It is expected that upon completion of the program, participants will be committed to a research or combined clinical/research career in Parkinson's and will be qualified to direct such programs. The second year of funding will depend on results of a progress report on the first year's work.
Applications are evaluated by PDF's Scientific Review Committee and the Clinical Research Subcommittee of the Science Committee of the AAN. The application deadline is February 1, 2007 for a July 1 start date. For more information, eligibility criteria and to apply, visit www.neurofoundation.org/research/erf.cfm or call Jane Wester at AANF at (651) 695-2755.